logo
Select company
Select metric
$ 0Net Income to Non-Controlling Interests
VS
Market
10
Sector
8
Industry
7
History
-
$ 0.51Close
$ 0.25 - $ 1.2 52-Week Range
Ticker Information

Ticker

RLYB

Company Name

RALLYBIO CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RALLYBIO CORP - Net Income to Non-Controlling Interests Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RLYB - Net Inc. NCI Historical data
DateNet Income to Non-Controlling Interests
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RALLYBIO CORP's latest trailing twelve months (TTM) Net Inc. NCI stands at $ 0.
  • Over the past 5 years, RALLYBIO CORP's average Net Inc. NCI has been $ 0.
  • The median Net Inc. NCI for RALLYBIO CORP during this period was $ 0
  • RALLYBIO CORP reached its highest Net Inc. NCI over the past 5 years at $ 0.
  • The lowest Net Inc. NCI recorded by RALLYBIO CORP in the same timeframe $ 0

RALLYBIO CORP's Net Inc. NCI vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. NCI Benchmarks
CompanyNet Inc. NCI
ICU : SEASTAR MEDICAL HOLDING CORP $ 0LEXX : LEXARIA BIOSCIENCE CORP $ -9.98KLYRA : LYRA THERAPEUTICS INC $ 0LSTA : LISATA THERAPEUTICS INC $ 0SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ 0PULM : PULMATRIX INC $ 0APRE : APREA THERAPEUTICS INC $ 0BRTX : BIORESTORATIVE THERAPIES INC $ 0IBIO : IBIO INC $ 0ERNA : ERNEXA THERAPEUTICS INC $ 0

Definition of Net Income to Non-Controlling Interests

[Income Statement] The portion of income which is attributable to non-controlling interest shareholders; subtracted from [ConsolInc] in order to obtain [NetInc].

RLYB - Net Income to Non-Controlling Interests, Last 5 years

$ 0

Minimum

Dec 31, 2020

$ 0

Maximum

Dec 31, 2020

$ 0

Average

$ 0

Median

Net Inc. NCI Benchmark Analysis

The chart above depicts the distribution of Net Inc. NCI for companies in the Total Stock Market. The average Net Inc. NCI of the companies is $ 11.12M with a standard deviation of $ 136.51M.
The following table provides additional summary stats:
Net Inc. NCI in the Market:
filtered constituents4.26K
min$ -1.8B
max$ 2.94B
average$ 11.12M
median$ 0
std$ 136.51M